Core Laboratories Inc

Core Laboratories NV engages in the provision of proprietary and patented reservoir description, production enhancement, and reservoir management services to the oil and gas industry. It operates through the following business segments: Reservoir Description and Production Enhancement. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid, and gas samples and provides analytical and field services to characterize properties of crude oil and petroleum products. The Production Enhancement segment provides products and services relating to reservoir well completions, perforations, stimulations, and production. The company was founded in 1936 and is headquartered in Amsterdam, the Netherlands.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Core Labs reports strong Q4 performance, eyes growth opportunities

Core Laboratories Inc delivered a solid performance in Q4 2022, focusing on financial strength, operational efficiency, and future growth prospects. Despite facing challenges from external factors, the company remains optimistic about opportunities in the energy sector and its ability to create value for shareholders.

Core Laboratories Inc reports robust Q1 earnings, eyes EOR opportunities

Core Laboratories Inc delivered strong financial results, highlighted operational efficiencies, and outlined growth strategies amidst industry challenges. The company's focus on innovation, debt reduction, and cost savings bodes well for future performance and shareholder value.

Core Labs reports solid Q2 performance, eyes international growth

Core Laboratories Inc showcased strong financial performance in Q2 2023, with a focus on operational efficiency and technological advancement.
The company's commitment to maximizing free cash flow, returns on invested capital, and shareholder value underscores its financial discipline and strategic priorities.
Despite challenges in the US land sector, Core Labs remains optimistic about international growth opportunities and technological advancements driving future success.

Core Laboratories Inc reports strong Q3 performance amidst market challenges

Core Laboratories Inc delivered a strong Q3 performance with improvements in key financial metrics. While facing challenges in certain segments, the company's strategic focus on innovation and efficiency positions it well for future opportunities. Core Labs remains optimistic about its outlook and is committed to driving growth and value for shareholders.

Core Laboratories reports steady Q4 performance amidst operational challenges

Core Laboratories navigated challenges in Q4 with a focus on debt reduction, innovation, and operational excellence, showcasing resilience and adaptability.
While facing headwinds in certain segments, Core Labs remains committed to long-term sustainability, shareholder value, and technological advancement.
Strategic initiatives and operational highlights underscore Core's leadership in the industry, setting the stage for future growth and market expansion.

Core Labs maintains steady performance amidst geopolitical challenges and debt reduction

Core Laboratories Inc delivered a resilient performance in Q1 2024, focusing on operational efficiency and debt reduction amidst external challenges.
The company's strategic strengths lie in international growth prospects, technology investments, and commitment to financial stability.
Challenges from geopolitical conflicts and operational disruptions highlight the need for adaptability and diversification in Core Labs' business approach.
Opportunities abound in capitalizing on international growth, technology advancements, and maximizing return on invested capital for sustainable growth.

Core Laboratories reports revenue growth and debt reduction in Q3

Core Laboratories Inc delivered a solid financial performance in Q3 2024, with revenue growth, improved margins, and reduced debt levels.
While facing challenges in a competitive market and capital expenditure constraints, the company remains focused on sustaining profitability and operational efficiency.
Opportunities lie in leveraging segment revenue growth, debt reduction strategies, and exploring new avenues for expansion and partnerships.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Core Laboratories Inc. provides proprietary and patented reservoir description and production enhancement services. The company was founded on May 1, 2023 and is headquartered in Houston, TX.

Core Laboratories (CLB) Q4 results benefit from cost-control initiatives and operational efficiencies.

Core Labs' (CLB) Q4 Earnings Meet, Sales Miss Estimates

Core Laboratories N.V. (CLB) CEO David Demshur on Q4 2019 Results - Earnings Call Transcript

Core Laboratories (CLB) delivered earnings and revenue surprises of 0.00% and 1.08%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Core Laboratories (CLB) Matches Q4 Earnings Estimates

The oil-field services company disappointed investors on many fronts.

Why Core Laboratories Stock Tumbled 14% in December

Core Labs (CLB) initiates a preliminary view for the first quarter of 2020 wherein it expects its quarterly revenues within $159-$164 million and earnings per share in the 39-41 cents range.

Core Labs (CLB) Cuts Quarterly Dividend, Revises Q4 Guidance

Core Laboratories (CLB) news for Tuesday concerning a guidance update for the fourth quarter of 2019 has CLB stock falling hard.
The post Core Laboratories News: CLB Stock Crumbles 21% on Guidance Cut appeared first on InvestorPlace.

Core Laboratories News: CLB Stock Crumbles 21% on Guidance Cut

The oil-field service company went back on its word to investors.

Why Core Laboratories Stock Is Cratering Today

Core Laboratories N.V. CLB, +1.15% said late Monday that it was slashing its fourth-quarter guidance, cutting its dividend and issued a first-quarter forecast.

Core Labs slashes dividend, fourth-quarter forecast

Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?

Why Is Core Laboratories (CLB) Up 3.6% Since Last Earnings Report?

Better crude oil market fundamentals are likely to scale up international activities, thereby boosting the prospects of Core Laboratories' (CLB) Reservoir Description unit.

Core Laboratories (CLB) Q3 Earnings and Sales Beat Estimates

Core Laboratories NV (CLB) CEO David Demshur on Q3 2019 Results - Earnings Call Transcript

Core Labs' third-quarter results came in right around the midpoint of its guidance range.

This Oil Stock's Earnings Were Right on Target Despite Turbulent Market Conditions

Core Laboratories (CLB) delivered earnings and revenue surprises of 4.17% and 0.93%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Core Laboratories (CLB) Surpasses Q3 Earnings and Revenue Estimates

Baker Hughes

TechnipFMC

Halliburton

Schlumberger

Although weak oil pricing and conservative capital spending by US explorers might have acted as headwinds in Q3, rising rig count in international market may have lent support to oilfield service.

What Lies Ahead for Oilfield Service in Q3 Earnings?

In this series, we look through the most recent Dividend Channel ''DividendRank'' report, and then we cherry pick only those companies that have experienced insider buying within the past six months.

Core Laboratories Named Top Dividend Stock With Insider Buying and 5.16% Yield

Forget about volatile oil prices, there are two other key factors that separate Baker Hughes and Core Labs.

Better Buy:  Baker Hughes vs. Core Laboratories N.V.

The oil reservoir specialist is riding crude oil’s wave today.

Why Core Labs Stock Is Spiking Today

First Solar

Pattern Energy Group

Investors looking at the sector should check out these players in oilfield services, solar panels, and renewable energy production.

3 Top Energy Stocks to Buy in September

MPLX

TerraForm Power

These three have one thing in common: strong management teams.

3 Top Energy Stocks to Buy Right Now: CLB, MPLX & TERP

This Fool couldn’t resist Core Labs’ recent sell-off.

3 Reasons I Just Bought This Oil Stock

Why Is Core Laboratories (CLB) Down 28.1% Since Last Earnings Report?

Analysts worry that oil reservoir specialist Core Labs' payout is unsustainable, but the company's executives have made it clear that they intend to maintain it.

This 5.5%-Yielding Dividend Isn’t Going Away

Energy Transfer LP Unit

Vestas Wind Systems A/S

This pipeline company, wind turbine maker, and oil reservoir specialist look like great buys in the energy sector these days.

3 Top Energy Stocks to Buy Right Now: Energy Transfer, Vestas Wind Systems & Core Laboratories

Core Labs (CLB) generates FCF of $10.1 million in Q2, marking the 71st consecutive quarter that the company has generated FCF.

Core Labs (CLB) Q2 Earnings In Line, Sales Miss Estimates

Core Laboratories N.V. (CLB) CEO David Demshur on Q2 2019 Results - Earnings Call Transcript

News for Core Laboratories Inc Stock (CLB)